Trial Profile
AN OPEN LABEL, BALANCED, RANDOMIZED, TWOTREATMENTS, SINGLE-PERIOD, SINGLE-DOSE, PARALLEL, COMPARATIVE SUBCUTANEOUS PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF PEGINTERFERON ALFA-2b 1.5 MICROGRAMS/KG OF INTAS BIOPHARMACEUTICALS LTD., AHMEDABAD, INDIA WITH VIRAFERONPEG OF SCHERING CORPORATION IN HEALTHY, ADULT, MALE, HUMAN SUBJECTS.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Nov 2019
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2b (Primary)
- Indications Hepatitis
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Intas Biopharmaceuticals
- 15 Feb 2012 Status changed from recruiting to completed Clinical Trials Registry - India.
- 29 Nov 2011 New trial record